Clinical Efficacy of Ertapenem for Recurrent Cystitis Caused by Multidrug-Resistant Extended-Spectrum β-Lactamase-Producing Escherichia coli in Female Outpatients

PURPOSE: To evaluate the clinical outcomes of ertapenem administered as an outpatient parenteral antibiotic therapy for intractable cystitis caused by extended-spectrum β-lactamase (ESBL)-producing Escherichia coli. MATERIALS AND METHODS: We retrospectively reviewed a case series of 3 years of thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Sungmin, Kim, Chulsung, Lim, Donghoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988439/
https://www.ncbi.nlm.nih.gov/pubmed/24741417
http://dx.doi.org/10.4111/kju.2014.55.4.270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988439/
https://www.ncbi.nlm.nih.gov/pubmed/24741417
http://dx.doi.org/10.4111/kju.2014.55.4.270

Ejemplares similares